+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ipsen Group - logo

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

From
Global Endocrinology Drugs Market 2021-2025 - Product Thumbnail Image

Global Endocrinology Drugs Market 2021-2025

  • Report
  • May 2021
  • 120 Pages
From
From
From
From
From
Neuroblastoma (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Neuroblastoma (Oncology) - Drugs in Development, 2021

  • Report
  • October 2021
  • 1265 Pages
From
Gliosarcoma (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Gliosarcoma (Oncology) - Drugs in Development, 2021

  • Report
  • October 2021
  • 575 Pages
From
From
From
Pheochromocytoma - Pipeline Insight, 2021 - Product Thumbnail Image

Pheochromocytoma - Pipeline Insight, 2021

  • Clinical Trials
  • March 2021
  • 60 Pages
From
From
Loading Indicator